Author: Shahram Vaezy
Location: Ctr. for Industrial and Medical Ultrasound, Appl. Phys. Lab., Univ. of Washington, Seattle, WA 98195
Author: Roy Martin
Location: Ctr. for Industrial and Medical Ultrasound, Appl. Phys. Lab., Univ. ofCtr. for Industrial and Medical Ultrasound, Appl. Phys. Lab., Univ. of Washington, Seattle, WA 98195
Author: Lawrence Crum
Location: Ctr. for Industrial and Medical Ultrasound, Appl. Phys. Lab., Univ. ofCtr. for Industrial and Medical Ultrasound, Appl. Phys. Lab., Univ. of Washington, Seattle, WA 98195
Abstract:
High Intensity Focused Ultrasound (HIFU) has been shown to provide an
effective method of hemostasis, in animal studies, for both solid organs and
blood vessels (acoustic hemostasis). Moderate to profuse bleeding from major
blood vessels, liver, and spleen, can be stopped within 1--2 min of HIFU
application. The efficacy of acoustic hemostasis has been demonstrated using
HIFU frequencies of 1--10 MHz, and acoustic intensities of 1000--5000 W/cm[sup
2]. Conventional B-mode ultrasound imaging and Doppler appear to provide a
effective visualization, targeting, and monitoring methods when extracorporeal
application, in case of internal bleeding, is desired. Both thermal and
mechanical mechanisms of HIFU appear to be responsible for achieving hemostasis.
The thermal mechanism, due to ultrasound absorption, raises the tissue
temperature in excess of 70
(degrees)C in less than a second, leading to
shrinkage of the tissue and collapse of small blood vessels. The mechanical
mechanism, due to cavitation activity, disrupts the tissue structure, leading to
the occlusion of large blood vessels. Both mechanisms result in coagulative
necrosis of tissue, and arrest of bleeding. Acoustic hemostasis may provide an
effective method in surgery and prehospital settings for treating bleeding in
trauma and elective surgery patients.
|